2002 Pivotal Phase 2 Results of AUGMENT-101 for Revumenib in KMT2Ar Acute Leukemia: Pediatric Experience

Abstract | Apr 3, 2024

Author

Zwaan CM, et al.

Congress

American Society of Pediatric Hematology/Oncology Conference

Seattle, Washington | Apr 3 – 6, 2024